To develop a high-throughput screen platform using our ABC-Myc cell lines, we optimized the NEJF10 cell line in 384-well plate and treated cells with drugs currently being used for clinical cancer treatment, including 125 FDA-approved cancer drugs. This evidence concerns the gene MYC and cancer.